Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor ...
The Mirror US on MSN17d
Expert reveals ‘well-kept secret’ tax break that could save you thousands
The little-known tax break, called the Retirement Savings Contributions Credit, could save earners $1,000 each ...
Pharmaceutical Technology on MSN16d
Medigene and EpimAb to develop T cell engagers for solid tumours
Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell engagers (TCR-TCEs), the “off-the-shelf” immunotherapies for solid tumours. The ...
Nature2y
How artificial intelligence is enabling T cell receptor screening for cell therapy discovery
T cells use T cell receptors (TCRs) to identify and eliminate diseased cells. T cells equipped with cancer-targeting TCRs can detect and eliminate cancer cells, and TCR-based T cell therapies have ...
Taiwan News6d
Teller Cash Recycler Market was Valued at US$ 4,143.47 Million in 2024
The global Teller Cash Recycler (TCR) market is experiencing robust growth, driven by advancements in cash management technologies and the rising demand for automation across banking, retail, and ...
TouringCarTimes10d
Maria Nienkötter joins Cobra Racing in TCR South America
Maria Nienkötter has been confirmed by Cobra Racing to drive one of their Toyota Corolla TCRs in the 2025 TCR South America ...